June 29, 2020 / 9:29 PM / 7 days ago

BRIEF-Verrica Pharmaceuticals Provides Regulatory Update On VP-102

June 29 (Reuters) - Verrica Pharmaceuticals Inc:

* VERRICA PHARMACEUTICALS PROVIDES REGULATORY UPDATE ON VP-102

* VERRICA PHARMACEUTICALS - GOT LETTER FROM FDAAS PART OF FDA’S ONGOING REVIEW OF COMPANY’S NEW DRUG APPLICATION FOR VP-102

* VERRICA PHARMACEUTICALS - LETTER SAYS THERE ARE DEFICIENCIES THAT PRECLUDE DISCUSSION OF LABELING, POST-MARKETING REQUIREMENTS FOR VP-102 AT THIS TIME

* VERRICA PHARMACEUTICALS - LETTER FURTHER STATES NOTIFICATION DOES NOT REFLECT FINAL DECISION ON INFORMATION UNDER REVIEW FOR VP-102

* VERRICA PHARMACEUTICALS - INTENDS TO WORK WITH FDA TO RESOLVE AND ADDRESS ANY ITEMS AS QUICKLY AS POSSIBLE Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below